WFH/X
Jul 25, 2025, 05:11
Global Study Sheds Light on Low-Dose Prophylaxis in Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
“A new study using data from WAPPS-Hemo explores the use of low-dose prophylaxis (LDP). The findings show that lower-income countries are more likely to adopt LDP highlighting the urgent need for equitable access.”
Read the full article here.
Title: A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
Authors: Dagmar M. Hajducek, Oceana Sinkovic, Pierre Chelle, Alfonso Iorio, Andrea Edginton
Stay informed with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests